{
  "id": 16936188,
  "title": "Personalized ovarian cancer vaccines spark immunity in phase 1 trial",
  "url": "https://urgent.news/2026/10/28/personalized-ovarian-cancer-vaccines-spark-immunity-in-phase-1-trial",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-28T17:20:05.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-personalized-ovarian-cancer-vaccines-immunity.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Rapidly dividing cancer cells can develop DNA mutations that produce abnormal proteins called antigens, which are unique to each patient's cancer. Scientists are now testing personalized cancer vaccines that target these neoantigens and prevent cancer from returning after treatment.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}